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years, as also noticed in the recent experi‑
ence of our reference centre [1,6], in both 
adults and children. Despite the virological 
and immunological effectiveness of cART, 
malignancies on the whole continue to 
involve patients living with HIV due to 
their increased life expectancy, the contin‑
ued exposure to many factors supporting 
cancer development, including environ‑
mental and life style co‑factors, as well as 
several co‑infections often accompany‑
INTRODUCTION
Even at the time of extensive availability 
of fully effective combination antiretrovi‑
ral therapies (cART), missed or delayed 
diagnosis of HIV infection or full‑blown 
AIDS remains proportionally frequent, 
as well as HIV disease presentations with 
multiple, concurrent opportunistic diseases 
[1‑5], including both AIDS‑defining and 
non‑AIDS‑defining disorders, which often 
make more and more difficult a prompt rec‑
ognition and management by complicating 
the differential diagnostic workup.
In particular, due to the dysregulation 
of cancer controlling immune‑mediated 
mechanisms persisting in HIV‑infected 
subjects also despite a completely con‑
trolled HIV replication achieved by cART, 
both AIDS‑related and AIDS‑unrelated 
neoplasms remain frequent during recent 
Why we describe this case
This case underlines the importance of 
a careful monitoring of HIV patients, 
because, even in the cART era, they may 
present with rare and rapidly lethal so‑
lid tumors
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Case report
Abstract
We aim to describe a patient with an already advanced HIV infection disclosed for the first 
time during a complex diagnostic workup, which detected a gross abdominal mass attributable 
to a poorly differentiated mesenchymal cancer with sarcomatoid features which rapidly led our 
patient to death, in absence of other potential HIV‑associated opportunistic diseases. Although 
extremely rare and rapidly lethal, our case report underscores the need of all caregivers who 
follow HIV‑infected patients also in the cART era to maintain an elevated attention toward 
infrequent, unexpected, and clinically atypical solid tumors, in order to ensure a timely diagnosis 
and management when possible.
Keywords: Rare solid tumors; Sarcomatoid features; Newly diagnosed HIV infection; Case 
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Tumore addominale con caratteristiche sarcomatoidi come esordio di malattia in un paziente 
con nuova diagnosi di infezione da HIV e nessun disturbo correlato all’AIDS. Caso clinico, 
caratteristiche cliniche e diagnostiche e discussione della letteratura
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Abdominal neoplasia with sarcomatoid 
features as the presenting illness of 
a patient with a newly diagnosed HIV 
infection and no AIDS‑related disorders. 
Case report, clinical and diagnostic 
features, and literature discussion
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ing HIV infection itself (i.e. HBV, HCV, 
HPV, HSV, HHV‑8, and EBV infections, 
among others), and a persisting immune 
system functional imbalance favoring the 
onset of tumors, in comparison with an epi‑
demiologically matched sample of general 
population, which is not harboring HIV 
infection [2‑5,7].
In particular, malignancies which are fre‑
quent in the general population often pres‑
ent with a clinical pathomorphism in our 
patient population, as in a case of atypical 
prostate cancer [8], and in some anecdotal 
presentations of Merkel cell carcinoma [9], 
and bladder and gastric cancer, respectively 
[10,11]. Very frequent associations with op‑
portunistic and non‑opportunistic disorders 
complicate even considerably the differential 
diagnostic pathway in multiple described 
case reports [1,2,6,7,12], in particular two 
cases of nasopharyngeal and rhinopharyn‑
geal carcinoma [12].
Aim of our report is to describe a patient 
with an already advanced HIV infection 
disclosed for the first time during a complex 
diagnostic workup, which finally pointed 
out a gross abdominal mass attributable to 
a poorly differentiated neoplasia with sar‑
comatoid features which rapidly led our 
patient to death, in absence of other poten‑
tial HIV‑associated opportunistic infections 
and diseases.
CASE REPORT
A 36‑year‑old homosexual man with 
a medical history including only surgery 
for a pilonidal cyst 6 year before, and se‑
rological anti‑HBV markers demonstrat‑
ing a prior hepatitis B infection, during 
the last 6 months suffered from increasing 
anorexia and weight loss, followed by an 
irregular, mild fever not responsive to em‑
piric broad‑spectrum antibiotic treatments. 
When hospitalized in a General Hospital of 
our metropolitan area, the early instrumen‑
tal examinations disclosed a parenchymal 
thickening of the lower left pulmonary lobe 
associated with a bilateral pleural effusion. 
Other imaging studies showed an enlarged 
spleen volume, diffuse lymphadenopathies 
along the main abdominal vessels, and a 
moderate peritoneal effusion, while no rel‑
evant abnormalities were detected with re‑
gard to liver and biliary tract. Posed on an 
empirical therapy with piperacillin‑tazo‑
bactam, the patient was referred to our in‑
patient centre.
Upon admission, the laboratory exami‑
nations showed a marked leukopenia (total 
white blood cells =  1,570/µl), anemia (due 
to an hemoglobin level = 8.9 g/dl), low se‑
rum iron levels (26 µg/dl) with elevated se‑
rum ferritin (1,456 ng/ml), and especially 
a very advanced T‑cell immunodeficiency, 
as sustained by a total CD4+ count of only 
19 cells/µl (3% of overall T cell subset). All 
other blood laboratory examinations and 
urinalysis tested within normal limits, save 
an increased C‑reactive protein (PCR) value 
(4.07 mg/dl).
Microbiological studies pointed out an 
elevated HIV viremia (112,181 HIV‑RNA 
copies/ml of a wild‑type HIV‑1 virus), in ab‑
sence of other active infections, which were 
carefully ruled out. In particular, repeated 
blood cultures for bacteria, fungi, and my‑
cobacteria tested negative, as well as serum 
Parvovirus B19, Cytomegalovirus, and Ep‑
stein‑Barr virus DNA search (only isolated 
anti‑EBV IgG antibodies were present). 
Leishmania and Toxoplasma gondii serologies 
proved negative, as well as Clostridium diffi‑
cile and Cryptosporidium search in the stools, 
stool cultures for other bacterial pathogens, 
urine antigens of Streptococcus pneumoniae 
and Legionella spp., and serum cryptococcal 
antigenemia and culture. With regard to ma‑
jor hepatitis viruses, HCV serology proved 
negative, while positive anti‑HBs and an‑
ti‑HBc antibodies represented the expected 
remnant of the previous documented HBV 
infection, in absence of dosable HBsAg se‑
rum levels. Ultrasonographic examination of 
the neck disclosed multiple, further lymph‑
adenopathies of reactive origin.
During our hospitalization, the empiric 
antibiotic therapy was initially simplified 
with ceftriaxone plus clarithromycin, and the 
day after admission a potent antiretroviral 
combination therapy was immediately intro‑
duced (emtricitabine‑tenofovir, plus daruna‑
vir 1200 mg/day plus ritonavir 200 mg/day), 
which proved well tolerated by our patient. 
After a 9‑day hospitalization characterized 
by substantially stable general conditions 
and isolated mild fever and diarrhea (prob‑
ably attributable to the recently discovered 
HIV infection and the severe underlying 
immunodeficiency), our patient was dis‑
charged, with treatment implemented with 
a chemoprophylaxis against Pneumocystis jir‑
oveci and Toxoplasma gondii (performed with 
atovaquone), fungi (with fluconazole), and 
atypical mycobacteria (with clarithromycin, 
maintained after the previous, empiric ad‑
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ministration for the presumed respiratory 
infection).
Because of the re‑appearance of irregular 
fever and an increased, bilateral pleural ef‑
fusion, our patient was hospitalized again 
after a couple of weeks. An ultrasonogra‑
phy‑guided thoracentesis of around 1000 
ml of fluid neither allowed a diagnosis (all 
microbiological, mycobacterial, and neo‑
plastic cell searches tested negative), nor a 
stabilization of the massive effusion, and was 
associated with increasing dyspnea, respira‑
tory insufficiency, chest pain, diffuse periph‑
eral edema, persisting anemia (requiring red 
blood cell transfusion), a worsening cachexia, 
and a rapid deterioration of general clinical 
conditions. As a consequence, our patient 
was moved to the Pulmonary Division, in 
order to try a surgical approach to the promi‑
nent pleural effusion.
A left trans‑thoracic parietal pleural bi‑
opsy (with positioning a of trans‑thoracic 
drainage), allowed to detect a first‑degree 
empyema, in absence of isolated microor‑
ganisms at microscopy, culture, and mo‑
lecular testing. Due to the concurrent, 
elevated fever, and increased serum ESR 
(erythrocyte sedimentation rate) and serum 
C‑reactive protein levels, an empiric antibi‑
otic therapy with piperacillin‑tazobactam 
was introduced, associated to an empiric 
treatment against atypical mycobacteria, 
all showing no significant effects against 
irregular fever and the rapidly deteriorat‑
ing general status. Quantiferon test proved 
negative. Subsequently, an elevated plasma 
HHV‑8 viremia (64,000 viral copies/ml), 
required a treatment with full‑dose intra‑
venous acyclovir. A bone marrow and a 
liver biopsy were also performed, which 
allowed to exclude hematological malig‑
nancies and eventual, other opportunistic 
infections and disease localizations. A pos‑
itron‑emission tomography (PET) showed 
multiple hypercaptation sites at both lungs 
and pleura, a right axillary adenopathy, and 
a diffuse but non‑specific abdominal hy‑
percaptation.
A further worsening of respiratory and 
general conditions occurred in the next few 
days, with appearance of obnubilation, le‑
targy, blurred vision, hypotension, abdominal 
distension, tendency to intestinal sub‑oc‑
clusion, and a persisting, diffuse edema. All 
these complications rapidly led to death de‑
spite an intensive supportive care performed 
in an intensive care unit of our hospital, the 
adjunct of meropenem and linezolid (among 
antimicrobial agents), and the prosecution of 
antiretroviral therapy and that of the empiric 
anti‑mycobacterial treament.
The necropsy assessment showed the fol‑
lowing macroscopic findings: a moderate 
edema at lower limbs, an abundant pleural 
effusion, a mild pericardic effusion, and a 
diffuse abdominal effusion (characterized 
by a clear, yellowish fluid). The respiratory 
tract showed an hyperemic and edematous 
laryngeal‑tracheal‑bronchial mucosa. Both 
lungs had a diffuse, increased consistency, a 
red‑greysh color, and contained a frankly 
increased amount of foamy fluid. When ex‑
amining the abdominal tract, the attention 
was immediately drawn on a voluminous 
grey‑yellowish mass of myxoid appearance, 
which incorporated the intestinal loops and 
the entire colonic tract, with an extensive 
and infiltrating behavior. The liver showed 
a significantly increased size. The remaining 
major abdominal organs (including pancre‑
as, kidneys, adrenal glands, and spleen) did 
not show relevant abnormalities, as well as 
all the main deep lymph node stations.
At microscopic examination, the abdomi‑
nal mass was constituted by a poorly differ‑
entiated neoplasia with sarcomatoid features 
(Figure 1).
A further typization with all the available 
histopathological technique was not feasible 
at our centre, thus confirming the extremely 
non‑differentiated features of this neoplasm.
The concurrent, massive, irregular lobu‑
lar necrosis of the liver was referrable to 
a terminal, vascular compression due to 
the above‑mentioned intrabdominal mass, 
which rapidly enlarged during the last days 
of life of our patient.
Figure 1. Microscopic 
examination of 
the abdominal 
mass: histology 
highlights a poorly 
differentiated neoplasia 
with sarcomatoid 
features. Further 
characterization of 
the neoplasm was not 
technically feasible
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DISCUSSION
When approaching the differential diag‑
nosis of rapidly growing abdominal masses 
in HIV‑infected patients, tuberculosis and 
atypical mycobacteriosis in their broad spec‑
trum of possible presentations remain the 
most frequent etiologies, starting from the 
pre‑cART era until now [2,13]. But this di‑
agnosis is neither obvious nor rapid; in our 
recent experience, an expansive abdominal 
mass leading to intestinal obstruction re‑
quired a very cumbersome and prolonged 
workup in order to exclude all possible in‑
fectious and neoplastic ethiologies, and was 
finally diagnosed and specifically treated 
with a 5‑month delay after its clinical ap‑
pearance, since only a positive culture for 
Mycobacterium avium‑intracellulare became 
positive from a biopsy specimen, when all 
other clinical, microbiological, molecular 
biology, imaging, and histopathologic stud‑
ies did not allow a disease identification in 
the meantime.
To add complication, a deep HIV‑related 
immunodeficiency may led to the first recog‑
nition of opportunistic infestations, includ‑
ing that due to a newly recognized cestode, 
which was initially responsible for a rapidly 
enlarging abdominal mass in a 1996 report 
[14]. On the other hand, the cART‑related 
immune reconstitution syndrome has been 
also described as the supporting cause of 
a pseudo‑tumoral abdominal mesenteric 
granulomatous mass, caused by an underly‑
ing mycobacterial infection plus inflamma‑
tion and edema [15].
When focusing our attention on malig‑
nancies, AIDS‑related ones remain frequent 
occurrences also in the cART era, with Ka‑
posi’s sarcoma as the leading cancer with 
mesenchymal origin [3‑5,16‑18]. However, 
among HIV‑infected children, Kaposi’s sar‑
coma and non‑Hodgkin’s lymphoma de‑
clined in their frequency during the cART 
era in a more significant way, compared with 
the same AIDS‑associated malignancies ob‑
served in adults.
In a recent review of case reports of sar‑
comas other than Kaposi’s sarcoma in the 
immunocompromised host (as a whole), 
Bhatia and coworkers identified 176 
non‑Kaposi’s sarcomas, 75 of them occur‑
ring in people with AIDS [18]. Leiomyo‑
sarcomas were the most frequently reported 
sarcomas according to histopathological 
assessments (101 cases), followed by an‑
giosarcomas (23 episodes), and fibrohystio‑
cytic tumors (17 cases). As already observed 
since the pre‑cART era [19], and during 
the cART era too [3,5,17‑20], smooth 
cell muscle neoplasms like leiomyosarco‑
mas linked with immunodeficiency and a 
concurrent Epstein‑Barr (EBV) infection, 
and often interested unusual body sites 
[19‑21]; leiomyomas were also reported 
with increased frequency among HIV‑in‑
fected patients, once again in conjunction 
with EBV infection [20]. Only one case of 
liposarcoma of the mediastinum has been 
reported in the international literature: in 
the year 1988 a 27‑year‑old man with a 
newly diagnosed HIV infection, who still 
had preserved peripheral T‑cell subsets 
(with an absolute CD4+ count of 660 cells/
µl) [22]. Histopathologic studies performed 
on the unresectable chest mass demon‑
strated a well differentiated liposarcoma 
of the de‑differentiated subtype [22]. The 
Authors underlined the unusual localiza‑
tion and the young age at presentation of 
this liposarcoma, which were deemed to be 
especially in patients who were still unaware 
of their underlying retroviral infection.
Although extremely rare and clinically 
untreatable, our case report underlines the 
need of health care personnel who follow 
HIV‑infected patients also in the cART era, 
to maintain an elevated attention level toward 
infrequent, unexpected, and clinically atypi‑
cal solid tumors, in order to ensure a timely 
diagnosis, and make possible a more detailed 
workup, and management when possible.
Key points
 y Nowadays, despite a completely controlled HIV replication achieved by cART, both 
AIDS‑related and AIDS‑unrelated neoplasms remain frequently diagnosed
 y Particular attention should be deserved to patients with a low CD4+ lymphocyte nadir, or 
a persistently impaired immune recovery, even during the cART era
 y Malignancies with high frequency in the general population often present with a clinical 
pathomorphism in HIV‑infected patients
 y Starting from the pre‑cART era until now, tuberculosis and atypical mycobacteriosis re‑
main the most frequent etiologies when dealing with the differential diagnosis of rapidly 
growing abdominal masses in HIV‑infected patients, but several other etiologies have been 
reported in the literature in this patient population
 y It is mandatory to maintain an elevated attention level toward infrequent, unexpected, 
and clinically atypical solid tumors, in order to ensure a timely diagnosis, and make pos‑
sible a more detailed workup, and management when feasible
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supported by the concurrent HIV disease 
[22]. Finally, only sparse cases of undiffer‑
entiated sarcomas have been anecdotally 
reported concurrently with HIV infection, 
as the patient described by Kotrashetti and 
coworkers in 2012 [23], who suffered from 
an intraosseous maxillary fibrosarcoma.
At our knowledge, such a poorly dif‑
ferentiated, gross and rapidly progressive 
sarcomatoid abdominal mass has not been 
reported in patients with HIV and AIDS, 
especially in patients who were still unaware 
of their underlying retroviral infection.
Although extremely rare and clinically 
untreatable, our case report underlines the 
need of health care personnel who follow 
HIV‑infected patients also in the cART era, 
to maintain an elevated attention level toward 
infrequent, unexpected, and clinically atypi‑
cal solid tumors, in order to ensure a timely 
diagnosis, and make possible a more detailed 
workup, and management when possible.
Key points
 y Nowadays, despite a completely controlled HIV replication achieved by cART, both 
AIDS‑related and AIDS‑unrelated neoplasms remain frequently diagnosed
 y Particular attention should be deserved to patients with a low CD4+ lymphocyte nadir, or 
a persistently impaired immune recovery, even during the cART era
 y Malignancies with high frequency in the general population often present with a clinical 
pathomorphism in HIV‑infected patients
 y Starting from the pre‑cART era until now, tuberculosis and atypical mycobacteriosis re‑
main the most frequent etiologies when dealing with the differential diagnosis of rapidly 
growing abdominal masses in HIV‑infected patients, but several other etiologies have been 
reported in the literature in this patient population
 y It is mandatory to maintain an elevated attention level toward infrequent, unexpected, 
and clinically atypical solid tumors, in order to ensure a timely diagnosis, and make pos‑
sible a more detailed workup, and management when feasible
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